Increased Medicare Part D Spending
According to new data released by the Centers for Medicare and Medicaid Services from 2013 to 2014 spending on Medicare
Read More
Part D/Prescription Drugs
Donald Trump’s trade talk is making the drug industry uneasy
(By Dylan Scott for STAT) WASHINGTON — The drug industry is quietly troubled over Donald Trump’s tough talk on trade. Continue reading
Read MoreACLU threatens to sue Colorado over hepatitis C drug restrictions
(By Ed Silverman for STAT) In the latest dust-up over the high cost of hepatitis C drugs, the American Civil
Read MoreSen. Hernandez Pulls Bill On Drug Price Transparency
(By Ana B. Ibarra for California Healthline) After being approved by a key committee last week, a bill that would
Read MoreScientists Engineer An Opioid That May Reduce Pain With Less Risk
(By Angus Chen for NPR) Once people realized that opioid drugs could cause addiction and deadly overdoses, they tried to
Read MoreUK patient groups urge government to negotiate drug prices
(By Ed Silverman for STAT) Arguing that cancer patients in the United Kingdom are missing out on new treatments, two
Read MoreJudge denies petition by supporters of California drug pricing ballot
(By Ed Silverman for STAT) Supporters of a California ballot measure, which is designed to lower drug prices, lost a
Read MoreLaws to shed light on drug pricing strategies probably won’t work
(By Ed Silverman for STAT) From coast to coast, state lawmakers are pushing legislation in hopes of putting a lid
Read MoreStudy Says FluMist Vaccine Does Indeed Work, Contradicting CDC
(By Tara Haelle for NPR) It came as a surprise this June when the Centers for Disease Control and Prevention
Read MoreBiosimilar names may affect pharmacist dispensing habits
(By Ed Silverman for STAT) What’s in a name? An awful lot when it comes to biosimilars. Continue reading article
Read More